Showing results (251-260 of 294) with videos related to

Sort By:
Pageof 30
Hepatology (Baltimore, Md.)|February 11, 2021
A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASHAmaro Taylor-Weiner, Harsha Pokkalla, Ling Han, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 26, 2025
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLDYasaman Vali, Anne-Marieke van Dijk, Jenny Lee, et al.
The New England Journal of Medicine|February 7, 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver FibrosisStephen A Harrison, Pierre Bedossa, Cynthia D Guy, et al.
Nature Communications|November 28, 2013
Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibitionQuentin M Anstee, Susanne Knapp, Edward P Maguire, et al.
Nature Reviews. Gastroenterology & Hepatology|September 27, 2025
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver diseaseLuis Antonio Diaz, Maja Thiele, Alexandre Louvet, et al.
Nature Genetics|June 2, 2009
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinAnn K Daly, Peter T Donaldson, Pallav Bhatnagar, et al.
The Lancet. Gastroenterology & Hepatology|January 18, 2021
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysisDavid Petroff, Valentin Blank, Philip N Newsome, et al.
Contemporary Clinical Trials|October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver diseaseTimothy Hardy, Kristy Wonders, Ramy Younes, et al.
The New England Journal of Medicine|April 23, 2015
Prednisolone or pentoxifylline for alcoholic hepatitisMark R Thursz, Paul Richardson, Michael Allison, et al.
Nature Medicine|November 4, 2024
Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitisHanna Pulaski, Stephen A Harrison, Shraddha S Mehta, et al.
Pageof 30